The webinar either no longer exists or an error has occured.
Date: December 11, 2018
Time: 1:00 pm  to  2:00 pm EST

There are a variety of tests that you may face during the process of your diagnosis which will likely affect your treatment decision making. Join this informative webinar where Scott Weissman, MS, CGC, will explain the difference between tumor and germline testing so that you can better understand the tests you receive and what they mean for you.

Your registration is important – even if you can’t attend live we’ll share the slides, video & audio of the presentation directly to you!


About the Presenter

Scott M. Weissman, MS, CGC

Scott M. Weissman is the founder of Chicago Genetic Consultants, LLC, a private genetic counseling practice.He received his Bachelor of Science degree in Biology from the University of Illinois at Urbana-Champaign in 1998.After graduation, he spent two years working in a clinical genetic testing laboratory at the University of Illinois at Chicago performing testing to monitor minimal residual disease in individuals affected by leukemia or lymphoma.In 2002, he graduated from Northwestern University in Chicago with his Masters of Science in Genetic Counseling. Scott practiced clinically at NorthShore University HealthSystem for 12 years and was the Program Manager at the Center for Medical Genetics.His primary focus was hereditary cancer syndromes (e.g., BRCA1/2, Lynch syndrome, hereditary diffuse gastric cancer) but also worked with individuals who had hereditary cardiac disease, neurologic conditions as well as a multitude of other adult onset genetic conditions and the burgeoning area of pharmacogenomics.

He also has experience with new genetic testing technologies and Next Generation Sequencing from his time with GeneDx, a clinical genetic testing company.Scott is currently a Clinical Faculty member at the Northwestern University Graduate Program in Genetic Counseling. He has been an active member of the National Society of Genetic Counselors (NSGC) where he has worked on a variety of committees and held positions as the Co-Chair of the Familial Cancer Risk Special Interest Group and Liaison to both the Commission on Cancer and the National Accreditation Program of Breast Centers, two programs housed in the American College of Surgeons. Scott is well known among his peers for his extensive work in the field and has authored numerous scholarly articles that have appeared in several prestigious publications such as Genetics in Medicine, Cancer, The Journal of the American Medical Association, and Journal of Genetic Counseling, to name a few.

Sponsored By:

no shavefightcrc_sponsor_bayer_web